217 related articles for article (PubMed ID: 19718787)
21. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
Magro CM; Kalomeris T; Roberts A
Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature.
Kempf W; Kazakov DV; Buechner SA; Graf M; Zettl A; Zimmermann DR; Tinguely M
Am J Dermatopathol; 2014 Aug; 36(8):661-6. PubMed ID: 24698939
[TBL] [Abstract][Full Text] [Related]
25. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
Aigner F; Korol D; Schmitt AM; Kurrer MO
Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
27. Programmed death-1 expression in cutaneous B-cell lymphoma.
Çetinözman F; Koens L; Jansen PM; Willemze R
J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager.
Ghatalia P; Porter J; Wroblewski D; Carlson JA
J Cutan Pathol; 2013 May; 40(5):477-84. PubMed ID: 23578183
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
Kelley JT; Brown NA; Hristov AC; Bresler SC
J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
[TBL] [Abstract][Full Text] [Related]
30. Primary Cutaneous B-cell Lymphomas.
Hope CB; Pincus LB
Clin Lab Med; 2017 Sep; 37(3):547-574. PubMed ID: 28802500
[TBL] [Abstract][Full Text] [Related]
31. CD30 expression in cutaneous B-cell lymphomas.
Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
Edinger JT; Kant JA; Swerdlow SH
Am J Surg Pathol; 2010 Dec; 34(12):1830-41. PubMed ID: 21107089
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous marginal-zone lymphoma.
Farhadian J; Terushkin V; Meehan SA; Latkowski JA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329553
[TBL] [Abstract][Full Text] [Related]
34. Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature.
Nicholson KM; Patel KP; Duvic M; Prieto VG; Tetzlaff MT
J Cutan Pathol; 2012 Sep; 39(9):866-71. PubMed ID: 22809282
[TBL] [Abstract][Full Text] [Related]
35. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
Fraga GR; Chow P
J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
[TBL] [Abstract][Full Text] [Related]
36. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
38. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.
Geyer JT; Ferry JA; Longtine JA; Flotte TJ; Harris NL; Zukerberg LR
Am J Clin Pathol; 2010 Jan; 133(1):59-69. PubMed ID: 20023259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
